Patent Judges Review Fewer Challenges as Agency Priorities Shift
Patent Judges Review Fewer Challenges as Agency Priorities Shift Read More »
Inventor Spotlight: Charles W. Hull
C4IP is honoring Charles W. Hull (born 1939), who has transformed manufacturing, medicine, and design through his invention of stereolithography — better known as 3D printing. Hull was born in Clifton, Colorado, and studied engineering physics at the University of Colorado before joining Ultraviolet Products, a company that used UV light to solidify liquid plastic
Inventor Spotlight: Charles W. Hull Read More »
Council for Innovation Promotion Urges Congress to Oppose the ETHIC Act
WASHINGTON (August 5, 2025) — Senators Peter Welch (D-VT), Josh Hawley (R-MO), and Amy Klobuchar (D-MN) recently introduced the Eliminating Thickets to Increase Competition (ETHIC) Act, S. 2276, in the U.S. Senate. This legislation would prohibit patent holders, specifically in the pharmaceutical sector, from asserting more than one patent out of a certain defined group
Council for Innovation Promotion Urges Congress to Oppose the ETHIC Act Read More »
Council for Innovation Promotion Applauds the EC’s Definitive Withdrawal of Standard Essential Patents Proposal
WASHINGTON (August 4, 2025) — Today, the Council for Innovation Promotion (C4IP) applauds the European Commission’s decision to decisively withdraw its proposed regulations on standard essential patents (SEPs). The proposal risked undermining innovation in Europe, the United States, and elsewhere, as well as the current system of industry-led negotiations based on fair, reasonable, and nondiscriminatory
C4IP Coalition Updates: July 2025
July Highlights: Congress Rejects Big Tech’s Push to Block AI Rules During last month’s deliberations on the One Big Beautiful Bill Act (OBBBA), Big Tech lobbyists pushed to include an “AI moratorium” provision that would have imposed a 10-year ban on state-level regulation of artificial intelligence. While the proposal was framed as a well-intentioned effort
C4IP Coalition Updates: July 2025 Read More »
This Month in IP: July 2025
Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From car safety to clean energy, every aspect of our lives has benefited greatly from IP, as shown by these historical examples from the month of July: 1962: On July 10, Nils Bohlen received a
This Month in IP: July 2025 Read More »
Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation
Earlier this year, a coalition of technology industry lobbyists sent a letter to President Trump urging his administration to weaken protections for standard-essential patents (SEPs) — patents that protect innovations incorporated into common, standardized technologies like 5G and Wi-Fi. Their letter reflected longstanding false narratives about SEPs and claimed that weakening SEP rights would benefit
Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation Read More »
Why C4IP Opposes the Drug Competition Enhancement Act and the Affordable Prescriptions for Patients Act
Congress is currently considering several ill-conceived bills that purport to address abuses in the patent system, but would, in reality, weaken core intellectual property protections. Among them are the Drug Competition Enhancement Act (S. 1040) and the Affordable Prescriptions for Patients Act (S. 1041). By attempting to devalue the United States’ robust intellectual property system,
